Efficacy and Safety of Intracameral Amphotericin B for Fungal Keratitis: A Systematic Review and Meta-Analysis

Key Points

• Intracameral amphotericin B demonstrates significant efficacy in treating fungal keratitis, reducing infection rates.
• In analyzing multiple studies, the pooled success rate of treatment was approximately 85% within specified follow-up periods.
• Systematic review and meta-analysis utilized various datasets to assess treatment results across different populations and methodologies.
• Safety profile indicates low rates of adverse effects, highlighting intracameral amphotericin B as a viable option in specific cases.